España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Centessa Pharmaceuticals
CNTA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$16.00
-1.5
-8.57%
At close: -
$16.00
0
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Q3 2024 Earnings were released on Tue Nov 12th, before the market open
Centessa Pharmaceuticals (CNTA) Forecast
News
Earnings
Centessa Pharmaceuticals (CNTA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Centessa Pharmaceuticals (NASDAQ:CNTA) Stock
Centessa Pharmaceuticals Stock (NASDAQ: CNTA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
Guggenheim Maintains Buy on Centessa Pharmace...
Benzinga Newsdesk
Tuesday, November 12, 2024
Centessa Pharmaceuticals Q3 2024 GAAP EPS $(0...
Benzinga Newsdesk
Thursday, September 26, 2024
Centessa Pharmaceuticals Shared New Preclinic...
Benzinga Newsdesk
Thursday, September 19, 2024
Morgan Stanley Upgrades Centessa Pharmaceutic...
Benzinga Newsdesk
B. Riley Securities Initiates Coverage On Cen...
Benzinga Newsdesk
Monday, September 16, 2024
BMO Capital Maintains Outperform on Centessa ...
Benzinga Newsdesk
Friday, September 13, 2024
Centessa Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Reported Earlier, Centessa Pharmaceuticals Pr...
Benzinga Newsdesk
Wednesday, September 11, 2024
Centessa Pharmaceuticals Announces $150M Prop...
Benzinga Newsdesk
Centessa Pharmaceuticals Files For Mixed Shel...
Benzinga Newsdesk
Guggenheim Maintains Buy on Centessa Pharmace...
Benzinga Newsdesk
Jefferies Maintains Buy on Centessa Pharmaceu...
Benzinga Newsdesk
Tuesday, September 10, 2024
Sleep-Disorder Focused Centessa Pharmaceuticals Unveils Interim Data From Lead Program In Acutely Sleep-Deprived Healthy Volunteers
Vandana Singh
Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Market-Moving News for September 10th
Benzinga Newsdesk
Centessa Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Centessa Pharmaceuticals Announced Interim Da...
Benzinga Newsdesk
Monday, September 09, 2024
BMO Capital Maintains Outperform on Centessa ...
Benzinga Newsdesk
Tuesday, August 27, 2024
Centessa Pharmaceuticals Announces Late-Break...
Benzinga Newsdesk
Wednesday, August 14, 2024
Oppenheimer Reiterates Outperform on Centessa...
Benzinga Newsdesk
Tuesday, August 13, 2024
Centessa Pharmaceuticals Q2 2024 GAAP EPS $(0...
Benzinga Newsdesk
Thursday, July 18, 2024
Oppenheimer Initiates Coverage On Centessa Ph...
Benzinga Newsdesk
Friday, June 21, 2024
Morgan Stanley Maintains Equal-Weight on Cent...
Benzinga Newsdesk
Monday, June 10, 2024
Centessa Pharma Taps John Crowley, as CFO, Ef...
Benzinga Newsdesk
Wednesday, April 24, 2024
Reported Earlier, Centessa Pharmaceuticals Pr...
Benzinga Newsdesk
Tuesday, April 23, 2024
Announces $100M Proposed Public Offering Of A...
Benzinga Newsdesk
Monday, April 22, 2024
The FDA Has Cleared Centessa Pharmaceuticals'...
Benzinga Newsdesk
Monday, April 01, 2024
BMO Capital Maintains Outperform on Centessa ...
Benzinga Newsdesk
Thursday, March 28, 2024
Centessa Pharmaceuticals Q4 EPS $(0.38) Beats...
Benzinga Newsdesk
Friday, February 09, 2024
Centessa Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Centessa Pharmaceuticals To Present Additiona...
Benzinga Newsdesk
Sunday, December 10, 2023
Centessa Pharmaceuticals Announced New Data From Additional 52-Weeks of Continuous Treatment From Third Year (Part 5) Of Ongoing Phase 2a Study Of SerpinPC For Treatment Of Hemophilia At 2023 ASH Meeting
Charles Gross
Monday, November 27, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Anaptys Expands Immune Cell Modulator Pipelin...
Benzinga Newsdesk
Wednesday, November 15, 2023
Centessa Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Jefferies Upgrades Centessa Pharmaceuticals t...
Benzinga Newsdesk
Monday, November 13, 2023
Centessa Pharmaceuticals Q3 EPS $(0.40) Beats...
Benzinga Newsdesk
Centessa Pharmaceuticals Had Cash, Cash Equiv...
Benzinga Newsdesk
Thursday, November 02, 2023
Centessa Pharmaceuticals To Present Additiona...
Benzinga Newsdesk
Tuesday, October 31, 2023
Centessa Pharmaceuticals Announces Dosing Of ...
Benzinga Newsdesk
Thursday, October 26, 2023
IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday
Lisa Levin
Morgan Stanley Upgrades Centessa Pharmaceutic...
Benzinga Newsdesk
Wednesday, October 25, 2023
Centessa Pharmaceuticals Announces Preclinica...
Benzinga Newsdesk
Thursday, August 24, 2023
The World Sleep Congress 2023 Released An Abs...
Benzinga Newsdesk
Tuesday, August 15, 2023
Where Centessa Pharmaceuticals Stands With Analysts
Benzinga Insights
SVB Securities Maintains Outperform on Centes...
Benzinga Newsdesk
Guggenheim Maintains Buy on Centessa Pharmace...
Benzinga Newsdesk
Goldman Sachs Maintains Neutral on Centessa P...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch